HbA1c 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The HbA1c Testing Market size is expected to reach USD 7.02 Billion in 2034 from USD 2.49 Billion (2025) growing at a CAGR of 12.2% during 2026-2034.

The HbA1c testing market is poised for significant growth, driven by the rising prevalence of diabetes and the increasing emphasis on preventive healthcare. As healthcare providers focus on early diagnosis and management of diabetes, HbA1c testing has emerged as a critical tool for monitoring long-term glucose control. This test not only aids in the diagnosis of diabetes but also plays a vital role in assessing the effectiveness of treatment regimens, making it indispensable in diabetes care.

Technological advancements in diagnostic testing are reshaping the HbA1c testing landscape. Innovations in point-of-care testing devices are enhancing accessibility and convenience, allowing patients to monitor their glucose levels more effectively. These devices provide rapid results, enabling timely interventions and personalized treatment plans. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols, thereby improving overall health outcomes.

The growing awareness of the importance of diabetes management is also driving market expansion. Public health initiatives aimed at educating individuals about the risks associated with uncontrolled diabetes are prompting more people to seek regular testing. As healthcare systems increasingly prioritize value-based care, the demand for reliable and accurate HbA1c testing solutions is expected to rise. In this evolving environment, stakeholders are well-positioned to capitalize on the growth potential of the HbA1c testing market, driving innovation and improving patient care in the process.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents
• Kits

By Technology

• Ion-exchange HPLC
• Enzymatic assay
• Affinity binding chromatography
• Turbidimetric inhibition immunoassay
• Others

By End User

• Hospitals and clinics
• Diagnostic laboratories
• Homecare
• Research institution
• Others

COMPANIES PROFILED

• Abbott, BioRad Laboratories, Inc, ARKRAY, Inc, Danaher, F HoffmannLa Roche Ltd, Siemens Healthcare GmbH, TransAsia BioMedicals, Trinity Biotech Ireland, EKF Diagnostics, Randox Laboratories Ltd, HemoCue India, Eurolyser Diagnostica GmbH, Sekisui Diagnostics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HBA1C TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Units)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL HBA1C TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN and Units)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Ion-exchange HPLC Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.3. Enzymatic assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.4. Affinity binding chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.5. Turbidimetric inhibition immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL HBA1C TESTING MARKET: BY END USER 2022-2034 (USD MN and Units)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.3. Diagnostic laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.5. Research institution Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL HBA1C TESTING MARKET: BY REGION 2022-2034(USD MN and Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HBA1C TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Bio-Rad LaboratoriesInc
  • 9.2.3 ARKRAYInc
  • 9.2.4 Danaher
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 Siemens Healthcare GmbH
  • 9.2.7 TransAsia Bio-Medicals
  • 9.2.8 Trinity Biotech Ireland
  • 9.2.9 EKF Diagnostics
  • 9.2.10 Randox Laboratories Ltd
  • 9.2.11 HemoCue India
  • 9.2.12 Eurolyser Diagnostica GmbH
  • 9.2.13 Sekisui Diagnostics